Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
An Assessment of Time Toxicity in Patients Receiving [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal: The oncologist
Published: June 18, 2026
Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 23, 2026
Old Dog, New Tricks: Oxybutynin for the Treatment of Androgen Deprivation Therapy-Related Vasomotor Symptoms.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 26, 2026
Subcutaneous Immunotherapy: It Is Time for Real-World Data.
Journal: JCO oncology practice
Published: March 02, 2026
Advances in Androgen Deprivation Therapy-Sparing Strategies: Ongoing Studies in Metastatic Castration-Sensitive Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: August 13, 2025
Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen.
Journal: Frontiers in oncology
Published: June 19, 2025
Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial.
Journal: European urology oncology
Published: February 04, 2025
Time's up: the urgency to investigate time toxicity in patients with genitourinary malignancies.
Journal: Therapeutic advances in medical oncology
Published: July 29, 2024
Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer.
Journal: Current oncology reports
Published: February 11, 2024
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).
Journal: European urology oncology
Published: February 10, 2024
Symptom Burden and Survivorship Care for Patients With Prostate Cancer on Androgen Deprivation Therapy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 18, 2023
Last Updated: 09/26/2026